This profile was last updated on
Is this you? Claim your profile.
(199 Total References)
Dr. Nathan ...
Dr. Nathan Ford
works holds a senior position in the Dept of HIV/AIDS and Global Hepatitis Programme where he
supports the development and implementation of guidelines.
He is also chair of the WHO Guideline Review Committee.
Prior to joining WHO he supported HIV programmes in a number of countries in southern Africa and South-East Asia, most recently as the Head of MSF's Medical Unit in South Africa.
He holds a degree in Microbiology and Virology, a Masters in Public Health and Epidemiology, and a PhD in Clinical Epidemiology.
Videos - EHCRC - Effective Health Care Research Consortium
Dr Nathan Ford,Â Department of HIV/AIDS and Global Hepatitis Programme, World Health Organization, Geneva
Liverpool School of Tropical Medicine
, Seminar Series: 3 February 2016
Dr. Nathan Ford, Ph.D.*+
Doctors Without Borders (MSF)
Events | MSF@IAS2011
Nathan Ford, Medical Coordinator, Access to Essential Medicines Campaign, MSF
MSF Press Conference
Nathan Ford, MSF Access Campaign Medical Director
Dr Nathan Ford presents at the ...
Dr Nathan Ford presents at the LSTM Seminar Series: 'Uses and limits of research evidence in shaping global HIV policy and practice'
Monday, 08 Feb 2016
LSTMâ€™s Seminar Series continued on February 3rd 2016 with a presentation by Dr Nathan Ford entitled:Â Uses and limits of research evidence in shaping global HIV policy and practice, which was introduced byÂ Dr Miriam Taegtmeyer, Senior Clinical Lecturer in theÂ Department of International and Public HealthÂ at LSTM.
had a long standing career at Medecins Sans Frontieresâ€Ž
(MSF) as Head of the Medical Unit in South Africa.
He is now at the heart of the World Health Organization (WHO) Department of HIV/AIDS and Global Hepatitis Programme in Geneva, where he works as a Programme Manager.
There he leads and contributes to guideline developmentÂ and chairs the Guidelines Review Committee.
talk by saying that the criteria for designing a study should be to ask an important question and answer it reliably.
In terms of collating evidence, he discussed the traditional research hierarchy spanning from case reports to meta-analysis, which will lead to policy development and practice change.Â He illustrated the gap between the acceptance of evidence and changes in policy and practice with the example of the 3-year delay by African countries to respond to changes in policy guidelines by the WHO for the treatment of severe malaria.Â
went on to explain the numerous issues surrounding delays in practice change following the release of guidelines by the WHO.Â Challenges include the feasibility of the new intervention, acceptability of it by the end-user and health provider, timing of the new intervention, applicability in all settings, cost, and local and international politics. Â He
explained each of these areas giving examples to demonstrate the challenges faced for HIV antiretroviral therapy (ART) and how some communities resolved these.
In particular, an intervention in which a small group of community members work together, allowing a different member to attend the clinic every month to pick up treatment for the whole group, reduced visits from every month to once in every six months.
also highlighted that global policy change can happen in the absence of evidence, citing the example in Malawi where nurses were permitted to prescribe ART to patients, as there were far more nurses than doctors.
This led to the change being adopted in a number of countries, with the benefits only being shown afterwards.
summarized by saying that an intervention might be sound in theory but it will be useless if it canâ€™t be taken to scale.
ended the presentation by suggesting ways we can ensure that research informs policy: by asking important questions, asking those questions at the right time, answering them reliably and considering the issues in context of the need.